BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res 2010;24:1423-32. [DOI: 10.1002/ptr.3207] [Cited by in Crossref: 289] [Cited by in F6Publishing: 244] [Article Influence: 26.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Lee F, Teng Y, Lingam CB, Chen Z, Sun M, Song Z, Balachander GM, Leo HL, Guo Q, Shah I, Yu H. Sequential drug delivery for liver diseases. Adv Drug Deliv Rev 2019;149-150:72-84. [PMID: 31734169 DOI: 10.1016/j.addr.2019.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Oryan A, Mohammadalipour A, Moshiri A, Tabandeh MR. Avocado/soybean unsaponifiables: a novel regulator of cutaneous wound healing, modelling and remodelling. Int Wound J 2015;12:674-85. [PMID: 24321012 DOI: 10.1111/iwj.12196] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
3 Latif AAE, Assar DH, Elkaw EM, Hamza HA, Alkhalifah DHM, Hozzein WN, Hamouda RA. Protective role of Chlorella vulgaris with Thiamine against Paracetamol induced toxic effects on haematological, biochemical, oxidative stress parameters and histopathological changes in Wistar rats. Sci Rep 2021;11:3911. [PMID: 33594164 DOI: 10.1038/s41598-021-83316-8] [Reference Citation Analysis]
4 Andrzejewska J, Martinelli T, Sadowska K. Silybum marianum : non-medical exploitation of the species: Silybum marianum : non-medical exploitation of the species. Ann Appl Biol 2015;167:285-97. [DOI: 10.1111/aab.12232] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
5 Iranshahy M, Iranshahi M, Abtahi SR, Karimi G. The role of nuclear factor erythroid 2-related factor 2 in hepatoprotective activity of natural products: A review. Food and Chemical Toxicology 2018;120:261-76. [DOI: 10.1016/j.fct.2018.07.024] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
6 Houghton CA, Fassett RG, Coombes JS. Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?Oxid Med Cell Longev. 2016;2016:7857186. [PMID: 26881038 DOI: 10.1155/2016/7857186] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 21.2] [Reference Citation Analysis]
7 Han X, Wang Z, Wang M, Li J, Xu Y, He R, Guan H, Yue Z, Gong M. Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration. Drug Deliv 2016;23:1818-29. [PMID: 26556526 DOI: 10.3109/10717544.2015.1108374] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
8 Yuan Z, Li Y, Liu Z, Feng S, Zhou H, Liu C, Liu L, Xie Y. Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies. Pharmacological Research 2018;128:153-66. [DOI: 10.1016/j.phrs.2017.09.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
9 Grimstein M, Huang SM. A regulatory science viewpoint on botanical-drug interactions. J Food Drug Anal 2018;26:S12-25. [PMID: 29703380 DOI: 10.1016/j.jfda.2018.01.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Rajnochová Svobodová A, Zálešák B, Biedermann D, Ulrichová J, Vostálová J. Phototoxic potential of silymarin and its bioactive components. Journal of Photochemistry and Photobiology B: Biology 2016;156:61-8. [DOI: 10.1016/j.jphotobiol.2016.01.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
11 Abenavoli L. Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease. Hepatol Res. 2011;41:668. [PMID: 21696523 DOI: 10.1111/j.1872-034x.2011.00823.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Zhao H, Michaelis ML, Blagg BS. Hsp90 Modulation for the Treatment of Alzheimer’s Disease. Current State of Alzheimer's Disease Research and Therapeutics. Elsevier; 2012. pp. 1-25. [DOI: 10.1016/b978-0-12-394816-8.00001-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
13 Puschner B, Wegenast C. Mushroom Poisoning Cases in Dogs and Cats: Diagnosis and Treatment of Hepatotoxic, Neurotoxic, Gastroenterotoxic, Nephrotoxic, and Muscarinic Mushrooms. Veterinary Clinics of North America: Small Animal Practice 2012;42:375-87. [DOI: 10.1016/j.cvsm.2011.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
14 Chen LJ, Lin XX, Guo J, Xu Y, Zhang SX, Chen D, Zhao Q, Xiao J, Lian GH, Peng SF, Guo D, Yang H, Shu Y, Zhou HH, Zhang W, Chen Y. Lrp6 Genotype affects Individual Susceptibility to Nonalcoholic Fatty Liver Disease and Silibinin Therapeutic Response via Wnt/β-catenin-Cyp2e1 Signaling. Int J Biol Sci 2021;17:3936-53. [PMID: 34671210 DOI: 10.7150/ijbs.63732] [Reference Citation Analysis]
15 Tabandeh MR, Oryan A, Mohhammad-alipour A, Tabatabaei-naieni A. Silibinin Regulates Matrix Metalloproteinase 3 (Stromelysine1) Gene Expression, Hexoseamines and Collagen Production During Rat Skin Wound Healing: REGULATION OF MMP3, HEXOSEAMINE AND COLLAGEN PRODUCTION BY SILIBININ. Phytother Res 2013;27:1149-53. [DOI: 10.1002/ptr.4839] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
16 Shi T, Wu L, Ma W, Ju L, Bai M, Chen X, Liu S, Yang X, Shi J. Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. Evid Based Complement Alternat Med 2020;2020:8749564. [PMID: 31998400 DOI: 10.1155/2020/8749564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
17 Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, Ding Y, Duan ZP, Fu QC, Guo XY, Hu P, Hu XQ, Jia JD, Lai RT, Li DL, Liu YX, Lu LG, Ma SW, Ma X, Nan YM, Ren H, Shen T, Wang H, Wang JY, Wang TL, Wang XJ, Wei L, Xie Q, Xie W, Yang CQ, Yang DL, Yu YY, Zeng MD, Zhang L, Zhao XY, Zhuang H;  Drug-induced Liver Injury (DILI) Study Group;  Chinese Society of Hepatology (CSH);  Chinese Medical Association (CMA). CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11:221-241. [PMID: 28405790 DOI: 10.1007/s12072-017-9793-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 23.0] [Reference Citation Analysis]
18 Cheilari A, Sturm S, Intelmann D, Seger C, Stuppner H. Head-to-Head Comparison of Ultra-High-Performance Liquid Chromatography with Diode Array Detection versus Quantitative Nuclear Magnetic Resonance for the Quantitative Analysis of the Silymarin Complex in Silybum marianum Fruit Extracts. J Agric Food Chem 2016;64:1618-26. [PMID: 26806429 DOI: 10.1021/acs.jafc.5b05494] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
19 Pérez-Sánchez A, Cuyàs E, Ruiz-Torres V, Agulló-Chazarra L, Verdura S, González-Álvarez I, Bermejo M, Joven J, Micol V, Bosch-Barrera J, Menendez JA. Intestinal Permeability Study of Clinically Relevant Formulations of Silibinin in Caco-2 Cell Monolayers. Int J Mol Sci 2019;20:E1606. [PMID: 30935093 DOI: 10.3390/ijms20071606] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
20 Roubalová L, Dinkova-Kostova AT, Biedermann D, Křen V, Ulrichová J, Vrba J. Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells. Fitoterapia 2017;119:115-20. [PMID: 28450126 DOI: 10.1016/j.fitote.2017.04.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
21 Lewis JH. The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond. Clin Gastroenterol Hepatol. 2015;13:2173-2189.e8. [PMID: 26116527 DOI: 10.1016/j.cgh.2015.06.017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
22 Tsimogiannis D, Oreopoulou V. Classification of Phenolic Compounds in Plants. Polyphenols in Plants. Elsevier; 2019. pp. 263-84. [DOI: 10.1016/b978-0-12-813768-0.00026-8] [Cited by in Crossref: 15] [Article Influence: 7.5] [Reference Citation Analysis]
23 Sozen H, Celik OI, Cetin ES, Yilmaz N, Aksozek A, Topal Y, Cigerci IH, Beydilli H. Evaluation of the Protective Effect of Silibinin in Rats with Liver Damage Caused by Itraconazole. Cell Biochem Biophys 2015;71:1215-23. [DOI: 10.1007/s12013-014-0331-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
24 Soares JMD, Pereira Leal AEB, Silva JC, Almeida JRGS, de Oliveira HP. Influence of Flavonoids on Mechanism of Modulation of Insulin Secretion. Pharmacogn Mag 2017;13:639-46. [PMID: 29200726 DOI: 10.4103/pm.pm_87_17] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
25 Huang G, Schramm S, Heilmann J, Biedermann D, Křen V, Decker M. Unconventional application of the Mitsunobu reaction: Selective flavonolignan dehydration yielding hydnocarpins. Beilstein J Org Chem 2016;12:662-9. [PMID: 27340458 DOI: 10.3762/bjoc.12.66] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
26 Bijak M. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism. Molecules 2017;22:E1942. [PMID: 29125572 DOI: 10.3390/molecules22111942] [Cited by in F6Publishing: 70] [Reference Citation Analysis]
27 Anwar S, Madkor HR, Ahmed N, Wagih ME. In vivo anticlastogenic effect of silymarin from milk thistle Silybum marianum L. Indian J Pharmacol 2018;50:108-15. [PMID: 30166747 DOI: 10.4103/ijp.IJP_660_16] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C. Oxaliplatin-Induced Neuropathy: Oxidative Stress as Pathological Mechanism. Protective Effect of Silibinin. The Journal of Pain 2012;13:276-84. [DOI: 10.1016/j.jpain.2011.11.009] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 11.4] [Reference Citation Analysis]
29 Zholobenko A, Modriansky M. Silymarin and its constituents in cardiac preconditioning. Fitoterapia 2014;97:122-32. [DOI: 10.1016/j.fitote.2014.05.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
30 Romanucci V, Di Fabio G, Zarrelli A. A New Class of Synthetic Flavonolignan-Like Dimers: Still Few Molecules, but with Attractive Properties. Molecules 2018;24:E108. [PMID: 30597952 DOI: 10.3390/molecules24010108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
31 Valentová K, Vidlář A, Zatloukalová M, Stuchlík M, Vacek J, Šimánek V, Ulrichová J. Biosafety and antioxidant effects of a beverage containing silymarin and arginine. A pilot, human intervention cross-over trial. Food and Chemical Toxicology 2013;56:178-83. [DOI: 10.1016/j.fct.2013.02.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
32 Keshavarz Afshar R, Chaichi MR, Ansari Jovini M, Jahanzad E, Hashemi M. Accumulation of silymarin in milk thistle seeds under drought stress. Planta 2015;242:539-43. [PMID: 25708739 DOI: 10.1007/s00425-015-2265-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
33 Tsaroucha AK, Valsami G, Kostomitsopoulos N, Lambropoulou M, Anagnostopoulos C, Christodoulou E, Falidas E, Betsou A, Pitiakoudis M, Simopoulos CE. Silibinin Effect on Fas/FasL, HMGB1, and CD45 Expressions in a Rat Model Subjected to Liver Ischemia-Reperfusion Injury. Journal of Investigative Surgery 2018;31:491-502. [DOI: 10.1080/08941939.2017.1360416] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
34 Sgorlon S, Stefanon B, Sandri M, Colitti M. Nutrigenomic activity of plant derived compounds in health and disease: Results of a dietary intervention study in dog. Res Vet Sci 2016;109:142-8. [PMID: 27892863 DOI: 10.1016/j.rvsc.2016.10.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
35 Pickova D, Ostry V, Toman J, Malir F. Presence of Mycotoxins in Milk Thistle (Silybum marianum) Food Supplements: A Review. Toxins (Basel) 2020;12:E782. [PMID: 33302488 DOI: 10.3390/toxins12120782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Mahi-birjand M, Karimzadeh I, Zarban A, Abdollahpour-alitappeh M, Saadatjoo SA, Ziaee M. Protective Effects of Silymarin on Gentamicin-Induced Nephrotoxicity in Infectious Patients: A Randomized Double Blinded Placebo-Controlled Clinical Trial. Pharm Sci 2020;26:287-95. [DOI: 10.34172/ps.2020.33] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Vrba J, Papoušková B, Roubalová L, Zatloukalová M, Biedermann D, Křen V, Valentová K, Ulrichová J, Vacek J. Metabolism of flavonolignans in human hepatocytes. J Pharm Biomed Anal 2018;152:94-101. [PMID: 29414024 DOI: 10.1016/j.jpba.2018.01.048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
38 Karkanis A, Bilalis D, Efthimiadou A. Cultivation of milk thistle (Silybum marianum L. Gaertn.), a medicinal weed. Industrial Crops and Products 2011;34:825-30. [DOI: 10.1016/j.indcrop.2011.03.027] [Cited by in Crossref: 56] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
39 Kosina P, Dokoupilová A, Janda K, Sládková K, Silberová P, Pivodová V, Ulrichová J. Effect of Silybum marianum fruit constituents on the health status of rabbits in repeated 42‐day fattening experiment. Animal Feed Science and Technology 2017;223:128-40. [DOI: 10.1016/j.anifeedsci.2016.11.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
40 Wang X, Gocek E, Novik V, Harrison JS, Danilenko M, Studzinski GP. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3). Cell Cycle 2010;9:4542-51. [PMID: 21084834 DOI: 10.4161/cc.9.22.13790] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
41 Wlcek K, Koller F, Ferenci P, Stieger B. Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. Drug Metab Dispos 2013;41:1522-8. [PMID: 23695864 DOI: 10.1124/dmd.113.051037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
42 Behrouj H, Ziamajidi N, Abbasalipourkabir R, Nasiri A, Soleimani Asl S. Therapeutic Effect of Silybum marianum Plant Extract on Tamoxifen-Induced Fatty Liver in Rats. Avicenna J Med Biochem 2015;3. [DOI: 10.17795/ajmb-27160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
43 Divella R, Daniele A, Savino E, Paradiso A. Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model. Cancer Genomics Proteomics 2020;17:335-50. [PMID: 32576579 DOI: 10.21873/cgp.20193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
44 Abenavoli L, Milic N. Silymarin for Liver Disease. Liver Pathophysiology. Elsevier; 2017. pp. 621-31. [DOI: 10.1016/b978-0-12-804274-8.00045-x] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
45 Abouzid S, Ahmed OM. Silymarin Flavonolignans. Elsevier; 2013. pp. 469-84. [DOI: 10.1016/b978-0-444-59603-1.00014-x] [Cited by in Crossref: 10] [Article Influence: 1.3] [Reference Citation Analysis]
46 Li X, Chen W, Simal-Gandara J, Georgiev MI, Li H, Hu H, Wu X, Efferth T, Wang S. West meets east: open up a dialogue on phytomedicine. Chin Med 2021;16:57. [PMID: 34281584 DOI: 10.1186/s13020-021-00467-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Alhusban A, Alkhazaleh E, El-Elimat T. Silymarin Ameliorates Diabetes-Induced Proangiogenic Response in Brain Endothelial Cells through a GSK-3β Inhibition-Induced Reduction of VEGF Release. J Diabetes Res 2017;2017:2537216. [PMID: 29209632 DOI: 10.1155/2017/2537216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
48 Kumar N, Jose J. Current developments in the nanomediated delivery of photoprotective phytochemicals. Environ Sci Pollut Res Int 2020;27:38446-71. [PMID: 32761528 DOI: 10.1007/s11356-020-10100-y] [Reference Citation Analysis]
49 Fallahzadeh MK, Dormanesh B, Sagheb MM, Roozbeh J, Vessal G, Pakfetrat M, Daneshbod Y, Kamali-sarvestani E, Lankarani KB. Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Kidney Diseases 2012;60:896-903. [DOI: 10.1053/j.ajkd.2012.06.005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 7.7] [Reference Citation Analysis]
50 Kalopitas G, Antza C, Doundoulakis I, Siargkas A, Kouroumalis E, Germanidis G, Samara M, Chourdakis M. Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis. Nutrition 2021;83:111092. [PMID: 33418491 DOI: 10.1016/j.nut.2020.111092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
51 Safarpoor M, Ghaedi M, Asfaram A, Yousefi-nejad M, Javadian H, Zare Khafri H, Bagherinasab M. Ultrasound-assisted extraction of antimicrobial compounds from Thymus daenensis and Silybum marianum: Antimicrobial activity with and without the presence of natural silver nanoparticles. Ultrasonics Sonochemistry 2018;42:76-83. [DOI: 10.1016/j.ultsonch.2017.11.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
52 Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL. Botanicals and Their Bioactive Phytochemicals for Women's Health. Pharmacol Rev 2016;68:1026-73. [PMID: 27677719 DOI: 10.1124/pr.115.010843] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
53 Voroneanu L, Siriopol D, Dumea R, Badarau S, Kanbay M, Afsar B, Gavrilovici C, Covic A. Addition of silymarin to renin–angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial. Int Urol Nephrol 2017;49:2195-204. [DOI: 10.1007/s11255-017-1697-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
54 Tilley C, Deep G, Agarwal C, Wempe MF, Biedermann D, Valentová K, Kren V, Agarwal R. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation. Mol Carcinog 2016;55:3-14. [PMID: 25492239 DOI: 10.1002/mc.22253] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
55 Dogan A, Anuk OO. Investigation of the phytochemical composition and antioxidant properties of chinar (Platanus orientalis L.) leaf infusion against ethanol-induced oxidative stress in rats. Mol Biol Rep 2019;46:3049-61. [PMID: 30864112 DOI: 10.1007/s11033-019-04741-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
56 Camini FC, Costa DC. Silymarin: not just another antioxidant. Journal of Basic and Clinical Physiology and Pharmacology 2020;31. [DOI: 10.1515/jbcpp-2019-0206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
57 Torres-gonzález L, Elsa Muñoz-espinosa L, María Rivas-estilla A, Trujillo-murillo K, Salazar-aranda R, Waksman De Torres N, Cordero-pérez P. Protective effect of four Mexican plants against CCl4-induced damage on the Huh7 human hepatoma cell line. Annals of Hepatology 2011;10:73-9. [DOI: 10.1016/s1665-2681(19)31590-x] [Cited by in Crossref: 16] [Article Influence: 1.6] [Reference Citation Analysis]
58 Eo HJ, Park GH, Jeong JB. Inhibition of Wnt Signaling by Silymarin in Human Colorectal Cancer Cells. Biomol Ther (Seoul) 2016;24:380-6. [PMID: 27068260 DOI: 10.4062/biomolther.2015.154] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
59 Eissa T, Palomino O, Carretero M, Gómez-serranillos M. Ethnopharmacological study of medicinal plants used in the treatment of CNS disorders in Sinai Peninsula, Egypt. Journal of Ethnopharmacology 2014;151:317-32. [DOI: 10.1016/j.jep.2013.10.041] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
60 Shi S, Klotz U. Drug Interactions with Herbal Medicines: . Clinical Pharmacokinetics 2012;51:77-104. [DOI: 10.2165/11597910-000000000-00000] [Cited by in Crossref: 78] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
61 Çeribaşı S, Türk G, Özçelik M, Doğan G, Çeribaşı AO, Mutlu Sİ, Erişir Z, Güvenç M, Güngören G, Acısu TC, Akarsu SA, Kaya ŞÖ, Sönmez M, Yüce A, Çiftçi M, Çambay Z, Bağcı E, Azman MA, Şimşek ÜG. Negative effect of feeding with high energy diets on testes and metabolic blood parameters of male Japanese quails, and positive role of milk thistle seed. Theriogenology 2020;144:74-81. [PMID: 31927417 DOI: 10.1016/j.theriogenology.2019.12.021] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A. Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. Nutr Cancer. 2013;65:590-599. [PMID: 23659451 DOI: 10.1080/01635581.2013.770043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
63 Rodríguez-Flores EM, Mata-Espinosa D, Barrios-Payan J, Marquina-Castillo B, Castañón-Arreola M, Hernández-Pando R. A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies. PLoS One 2019;14:e0217457. [PMID: 31145751 DOI: 10.1371/journal.pone.0217457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Buzzetti E, Kalafateli M, Thorburn D, Davidson BR, Thiele M, Gluud LL, Del Giovane C, Askgaard G, Krag A, Tsochatzis E, Gurusamy KS. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. Cochrane Database Syst Rev 2017;3:CD011646. [PMID: 28368093 DOI: 10.1002/14651858.CD011646.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
65 Vue B, Zhang S, Vignau A, Chen G, Zhang X, Diaz W, Zhang Q, Zheng S, Wang G, Chen QH. O-Aminoalkyl-O-Trimethyl-2,3-Dehydrosilybins: Synthesis and In Vitro Effects Towards Prostate Cancer Cells. Molecules 2018;23:E3142. [PMID: 30501133 DOI: 10.3390/molecules23123142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Althagafy HS, Meza-Aviña ME, Oberlies NH, Croatt MP. Mechanistic study of the biomimetic synthesis of flavonolignan diastereoisomers in milk thistle. J Org Chem 2013;78:7594-600. [PMID: 23876147 DOI: 10.1021/jo4011377] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
67 Cao X, Deng W, Fu M, Zhu Y, Liu H, Wang L, Zeng J, Wei Y, Xu X, Yu J. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: In vitro release kinetics and in vitro/in vivo correlations in beagle dogs. European Journal of Pharmaceutical Sciences 2013;48:64-71. [DOI: 10.1016/j.ejps.2012.10.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
68 Cao X, Deng WW, Fu M, Wang L, Tong SS, Wei YW, Xu Y, Su WY, Xu XM, Yu JN. In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles. Int J Nanomedicine 2012;7:753-62. [PMID: 22393284 DOI: 10.2147/IJN.S28348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
69 Zhao H, Brandt GE, Galam L, Matts RL, Blagg BS. Identification and initial SAR of silybin: an Hsp90 inhibitor. Bioorg Med Chem Lett 2011;21:2659-64. [PMID: 21273068 DOI: 10.1016/j.bmcl.2010.12.088] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
70 Colica C, Boccuto L, Abenavoli L. Silymarin: An option to treat non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(47): 8437-8438 [PMID: 29309065 DOI: 10.3748/wjg.v23.i47.8437] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
71 Akhlaghi M. Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids: Flavonoids and Non-alcoholic Fatty Liver. Phytother Res 2016;30:1559-71. [DOI: 10.1002/ptr.5667] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
72 Ali SO, Darwish HA, Ismail NA. Curcumin, Silybin Phytosome(®) and α-R-Lipoic Acid Mitigate Chronic Hepatitis in Rat by Inhibiting Oxidative Stress and Inflammatory Cytokines Production. Basic Clin Pharmacol Toxicol 2016;118:369-80. [PMID: 26457982 DOI: 10.1111/bcpt.12502] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
73 Khorsandi L, Saki G, Bavarsad N, Mombeini M. Silymarin induces a multi-targeted cell death process in the human colon cancer cell line HT-29. Biomed Pharmacother. 2017;94:890-897. [PMID: 28810529 DOI: 10.1016/j.biopha.2017.08.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
74 Lai F, Schlich M, Pireddu R, Fadda AM, Sinico C. Nanocrystals as Effective Delivery Systems of Poorly Water-soluble Natural Molecules. Curr Med Chem 2019;26:4657-80. [PMID: 30543163 DOI: 10.2174/0929867326666181213095809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
75 Taghipour A, Ghaffarifar F, Horton J, Dalimi A, Sharifi Z. Silybum marianum ethanolic extract: in vitro effects on protoscolices of Echinococcus granulosus G1 strain with emphasis on other Iranian medicinal plants. Trop Med Health 2021;49:71. [PMID: 34496975 DOI: 10.1186/s41182-021-00363-7] [Reference Citation Analysis]
76 Magielse J, Arcoraci T, Breynaert A, Dooren IV, Kanyanga C, Fransen E, Hoof VV, Vlietinck A, Apers S, Pieters L, Hermans N. Antihepatotoxic activity of a quantified Desmodium adscendens decoction and d-pinitol against chemically-induced liver damage in rats. Journal of Ethnopharmacology 2013;146:250-6. [DOI: 10.1016/j.jep.2012.12.039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
77 Martinelli T, Fulvio F, Pietrella M, Focacci M, Lauria M, Paris R. In Silybum marianum Italian wild populations the variability of silymarin profiles results from the combination of only two stable chemotypes. Fitoterapia 2021;148:104797. [PMID: 33271258 DOI: 10.1016/j.fitote.2020.104797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
78 Hall JA, Forsberg LK, Blagg BS. Alternative approaches to Hsp90 modulation for the treatment of cancer. Future Med Chem 2014;6:1587-605. [PMID: 25367392 DOI: 10.4155/fmc.14.89] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
79 Chen X, Deng X, Han X, Liang Y, Meng Z, Liu R, Su W, Zhu H, Fu T. Inhibition of Lysozyme Amyloid Fibrillation by Silybin Diastereoisomers: The Effects of Stereochemistry. ACS Omega 2021;6:3307-18. [PMID: 33553948 DOI: 10.1021/acsomega.0c05788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Xie Y, Miranda SR, Hoskins JM, Hawke RL. Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD. Molecules 2017;22:E142. [PMID: 28098838 DOI: 10.3390/molecules22010142] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
81 Gao X, Xiao Z, Liu M, Zhang N, Khalil MM, Gu C, Qi D, Sun L. Dietary Silymarin Supplementation Alleviates Zearalenone-Induced Hepatotoxicity and Reproductive Toxicity in Rats. The Journal of Nutrition 2018;148:1209-16. [DOI: 10.1093/jn/nxy114] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
82 Marin V, Gazzin S, Gambaro SE, Dal Ben M, Calligaris S, Anese M, Raseni A, Avellini C, Giraudi PJ, Tiribelli C, Rosso N. Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis. Nutrients 2017;9:E1006. [PMID: 28895929 DOI: 10.3390/nu9091006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
83 Hu X, Qin N, Xue J, Li S, Huang X, Sun J, Xu F, Li Z, Li D, Hua H. Dehydrodiconiferyl alcohol from Silybum marianum (L.) Gaertn accelerates wound healing via inactivating NF-κB pathways in macrophages. Journal of Pharmacy and Pharmacology 2020;72:305-17. [DOI: 10.1111/jphp.13205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
84 de Oliveira DR, Schaffer LF, Busanello A, Barbosa CP, Peroza LR, de Freitas CM, Krum BN, Bressan GN, Boligon AA, Athayde ML, de Menezes IRA, Fachinetto R. Silymarin has antioxidant potential and changes the activity of Na+/K+-ATPase and monoamine oxidase in vitro. Industrial Crops and Products 2015;70:347-55. [DOI: 10.1016/j.indcrop.2015.03.060] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
85 Thiel C, Thiel K, Klingert W, Diewold A, Scheuermann K, Hawerkamp E, Lauber J, Scheppach J, Morgalla MH, Königsrainer A, Schenk M. The enterohepatic circulation of amanitin: Kinetics and therapeutical implications. Toxicology Letters 2011;203:142-6. [DOI: 10.1016/j.toxlet.2011.03.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
86 Milic S, Mikolasevic I, Krznaric-Zrnic I, Stanic M, Poropat G, Stimac D, Vlahovic-Palcevski V, Orlic L. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options. Drug Des Devel Ther 2015;9:4835-45. [PMID: 26316717 DOI: 10.2147/DDDT.S64877] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
87 Kim MJ, Kim DU, Choi JW, Kim DG, Song HJ, Bae GS, Park SJ. Silymarin Attenuates the Severity of Cerulein-Induced Acute Pancreatitis. Pancreas 2020;49:89-95. [PMID: 31856083 DOI: 10.1097/MPA.0000000000001453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Maldonado-Rojas W, Olivero-Verbel J. Food-related compounds that modulate expression of inducible nitric oxide synthase may act as its inhibitors. Molecules. 2012;17:8118-8135. [PMID: 22766803 DOI: 10.3390/molecules17078118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
89 Sokolová R, Kocábová J, Marhol P, Fiedler J, Biedermann D, Vacek J, Křen V. Oxidation of Natural Bioactive Flavonolignan 2,3-Dehydrosilybin: An Electrochemical and Spectral Study. J Phys Chem B 2017;121:6841-6. [DOI: 10.1021/acs.jpcb.7b04651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
90 Mahli A, Koch A, Czech B, Peterburs P, Lechner A, Haunschild J, Müller M, Hellerbrand C. Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats. Clin Phytosci 2015;1. [DOI: 10.1186/s40816-015-0006-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
91 Liang L, Li FJ, Liu X, Mu JK, Wang X, Dong JC, Zeng LX, Gu W, Li JP, Yang XX, Yu J. Identification of Mitochondrial Ligands with Hepatoprotective Activity from Notopterygii Rhizoma et Radix Using Affinity Ultrafiltration/Liquid Chromatography/Mass Spectrometry. Biomed Res Int 2019;2019:5729263. [PMID: 31950043 DOI: 10.1155/2019/5729263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Lo D, Wang Y, Wu M. Hepatoprotective effect of silymarin on di(2-ethylhexyl)phthalate (DEHP) induced injury in liver FL83B cells. Environmental Toxicology and Pharmacology 2014;38:112-8. [DOI: 10.1016/j.etap.2014.05.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
93 Bijak M, Szelenberger R, Saluk J, Nowak P. Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood. Int J Biol Macromol 2017;95:682-8. [PMID: 27923566 DOI: 10.1016/j.ijbiomac.2016.12.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
94 Sarandy MM, Lopes FB, da Matta SL, Pinto MV, Sartori SS, Novaes RD, Golçalves RV. Effect of Topical Administration of Fractions and Isolated Molecules from Plant Extracts on Skin Wound Healing: A Systematic Review of Murine Experimental Models. Mediators Inflamm 2016;2016:4916068. [PMID: 27829707 DOI: 10.1155/2016/4916068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
95 Sulas L, Re GA, Bullitta S, Piluzza G. Chemical and productive properties of two Sardinian milk thistle (Silybum marianum (L.) Gaertn.) populations as sources of nutrients and antioxidants. Genet Resour Crop Evol 2016;63:315-26. [DOI: 10.1007/s10722-015-0251-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
96 Abenavoli L, Greco M, Nazionale I, Peta V, Milic N, Accattato F, Foti D, Gulletta E, Luzza F. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2015;9:519-527. [PMID: 25617046 DOI: 10.1586/17474124.2015.1004312] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 8.5] [Reference Citation Analysis]
97 Zhang S, Vue B, Huang M, Zhang X, Lee T, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells. Bioorg Med Chem Lett 2016;26:3226-31. [PMID: 27261177 DOI: 10.1016/j.bmcl.2016.05.069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
98 Luo M, Xu H, Dong Y, Shen K, Lu J, Yin Z, Qi M, Sun G, Tang L, Xiang J, Deng Z, Dickschat JS, Sun Y. The Mechanism of Dehydrating Bimodules in trans-Acyltransferase Polyketide Biosynthesis: A Showcase Study on Hepatoprotective Hangtaimycin. Angew Chem Int Ed Engl 2021;60:19139-43. [PMID: 34219345 DOI: 10.1002/anie.202106250] [Reference Citation Analysis]
99 Zarrouk A, Martine L, Grégoire S, Nury T, Meddeb W, Camus E, Badreddine A, Durand P, Namsi A, Yammine A, Nasser B, Mejri M, Bretillon L, Mackrill JJ, Cherkaoui-Malki M, Hammami M, Lizard G. Profile of Fatty Acids, Tocopherols, Phytosterols and Polyphenols in Mediterranean Oils (Argan Oils, Olive Oils, Milk Thistle Seed Oils and Nigella Seed Oil) and Evaluation of their Antioxidant and Cytoprotective Activities. Curr Pharm Des 2019;25:1791-805. [PMID: 31298157 DOI: 10.2174/1381612825666190705192902] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 26.0] [Reference Citation Analysis]
100 Montonye ML, Tian DD, Arman T, Lynch KD, Hagenbuch B, Paine MF, Clarke JD. A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model. J Pharmacol Exp Ther 2019;371:385-93. [PMID: 31420525 DOI: 10.1124/jpet.119.260489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
101 Althagafy HS, Graf TN, Sy-Cordero AA, Gufford BT, Paine MF, Wagoner J, Polyak SJ, Croatt MP, Oberlies NH. Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle. Bioorg Med Chem 2013;21:3919-26. [PMID: 23673225 DOI: 10.1016/j.bmc.2013.04.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
102 Lv Y, Gao S, Xu S, Du G, Zhou J, Chen J. Spatial organization of silybin biosynthesis in milk thistle [Silybum marianum (L.) Gaertn]. Plant J 2017;92:995-1004. [PMID: 28990236 DOI: 10.1111/tpj.13736] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
103 Mengesha T, Gnanasekaran N, Mehare T. Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats. BMC Complement Med Ther 2021;21:104. [PMID: 33785007 DOI: 10.1186/s12906-021-03275-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 van Wenum E, Jurczakowski R, Litwinienko G. Media Effects on the Mechanism of Antioxidant Action of Silybin and 2,3-Dehydrosilybin: Role of the Enol Group. J Org Chem 2013;78:9102-12. [DOI: 10.1021/jo401296k] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
105 Rosato V, Abenavoli L, Federico A, Masarone M, Persico M. Pharmacotherapy of alcoholic liver disease in clinical practice. Int J Clin Pract. 2016;70:119-131. [PMID: 26709723 DOI: 10.1111/ijcp.12764] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
106 Vargas-Pozada EE, Muriel P. Herbal medicines for the liver: from bench to bedside. Eur J Gastroenterol Hepatol 2020;32:148-58. [PMID: 31895207 DOI: 10.1097/MEG.0000000000001485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
107 Oltean M. Silybin Against Liver Ischemia-Reperfusion Injury: Something Old, Something New…. J Invest Surg 2018;31:521-2. [PMID: 28901794 DOI: 10.1080/08941939.2017.1365975] [Reference Citation Analysis]
108 Gupta S, Gupta YK. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats. Journal of Ethnopharmacology 2017;197:118-27. [DOI: 10.1016/j.jep.2016.07.060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
109 Zatloukalová M, Křen V, Gažák R, Kubala M, Trouillas P, Ulrichová J, Vacek J. Electrochemical investigation of flavonolignans and study of their interactions with DNA in the presence of Cu(II). Bioelectrochemistry 2011;82:117-24. [PMID: 21764394 DOI: 10.1016/j.bioelechem.2011.06.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
110 Shen L, Liu L, Li XY, Ji HF. Regulation of gut microbiota in Alzheimer's disease mice by silibinin and silymarin and their pharmacological implications. Appl Microbiol Biotechnol 2019;103:7141-9. [PMID: 31236617 DOI: 10.1007/s00253-019-09950-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
111 Xie Y, Hao HP, Wang H, Wang ZX, Wang GJ. Reversing effects of silybin on TAA-induced hepatic CYP3A dysfunction through PXR regulation. Chin J Nat Med 2013;11:645-52. [PMID: 24345506 DOI: 10.1016/S1875-5364(13)60075-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
112 Alcaraz-Contreras Y, Mendoza-Lozano RP, Martínez-Alcaraz ER, Martínez-Alfaro M, Gallegos-Corona MA, Ramírez-Morales MA, Vázquez-Guevara MA. Silymarin and dimercaptosuccinic acid ameliorate lead-induced nephrotoxicity and genotoxicity in rats. Hum Exp Toxicol 2016;35:398-403. [PMID: 26078282 DOI: 10.1177/0960327115591373] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
113 Taleb A, Ahmad KA, Ihsan AU, Qu J, Lin N, Hezam K, Koju N, Hui L, Qilong D. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomedicine & Pharmacotherapy 2018;102:689-98. [DOI: 10.1016/j.biopha.2018.03.140] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 18.3] [Reference Citation Analysis]
114 Wu T, Liu W, Guo W, Zhu X. Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells. Biomed Pharmacother 2016;81:460-7. [PMID: 27261626 DOI: 10.1016/j.biopha.2016.04.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
115 Bijak M, Saluk J, Szelenberger R, Nowak P. Popular naturally occurring antioxidants as potential anticoagulant drugs. Chem Biol Interact 2016;257:35-45. [PMID: 27475864 DOI: 10.1016/j.cbi.2016.07.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
116 Poulos JE, Kalogerinis PT, Milanov V, Kalogerinis CT, Poulos EJ. The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease. J Diet Suppl 2021;:1-16. [PMID: 33491528 DOI: 10.1080/19390211.2021.1874587] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 da Silva TF, Ferraz AC, Almeida LT, Caetano CCDS, Camini FC, Lima RLS, Andrade ACDSP, de Oliveira DB, Rocha KLS, Silva BDM, de Magalhães JC, Magalhães CLDB. Antiviral effect of silymarin against Zika virus in vitro. Acta Tropica 2020;211:105613. [DOI: 10.1016/j.actatropica.2020.105613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
118 Hassan SMS, Youakim MF, Rizk AAE, Thomann C, Ahmad Z. Does silybin protect against toxicity induced by polymyxin E in rat kidney? Neurourol Urodyn 2017;36:1278-87. [PMID: 27574823 DOI: 10.1002/nau.23109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
119 Csupor D, Csorba A, Hohmann J. Recent advances in the analysis of flavonolignans of Silybum marianum. J Pharm Biomed Anal. 2016;130:301-317. [PMID: 27321822 DOI: 10.1016/j.jpba.2016.05.034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 6.6] [Reference Citation Analysis]
120 Viktorova J, Stranska-Zachariasova M, Fenclova M, Vitek L, Hajslova J, Kren V, Ruml T. Complex Evaluation of Antioxidant Capacity of Milk Thistle Dietary Supplements. Antioxidants (Basel) 2019;8:E317. [PMID: 31426591 DOI: 10.3390/antiox8080317] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
121 Evren E, Yurtcu E. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiol (Praha) 2015;60:351-6. [PMID: 25937395 DOI: 10.1007/s12223-015-0399-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
122 Martinelli T, Potenza E, Moschella A, Zaccheria F, Benedettelli S, Andrzejewska J. Phenotypic Evaluation of a Milk Thistle Germplasm Collection: Fruit Morphology and Chemical Composition. Crop Science 2016;56:3160-72. [DOI: 10.2135/cropsci2016.03.0162] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
123 Singh L, Joshi T, Tewari D, Echeverría J, Mocan A, Sah AN, Parvanov E, Tzvetkov NT, Ma ZF, Lee YY, Poznański P, Huminiecki L, Sacharczuk M, Jóźwik A, Horbańczuk JO, Feder-Kubis J, Atanasov AG. Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook. Front Pharmacol 2019;10:1593. [PMID: 32116660 DOI: 10.3389/fphar.2019.01593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
124 Bijak M, Szelenberger R, Dziedzic A, Saluk-Bijak J. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets. Molecules 2018;23:E374. [PMID: 29439388 DOI: 10.3390/molecules23020374] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
125 Zangani E, Zehtab‐salmasi S, Andalibi B, Zamani A. Protective Effects of Nitric Oxide on Photosynthetic Stability and Performance of Silybum marianum under Water Deficit Conditions. Agron j 2018;110:555-64. [DOI: 10.2134/agronj2017.07.0396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
126 Mendez-Sanchez N, Cruz-Ramon VC, Ramirez-Perez OL, Hwang JP, Barranco-Fragoso B, Cordova-Gallardo J. New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. Int J Mol Sci. 2018;19. [PMID: 30011790 DOI: 10.3390/ijms19072034] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 20.3] [Reference Citation Analysis]
127 Albassam AA, Frye RF, Markowitz JS. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes. Chemico-Biological Interactions 2017;271:24-9. [DOI: 10.1016/j.cbi.2017.04.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
128 Bittencourt MLF, Rodrigues RP, Kitagawa RR, Gonçalves RCR. The gastroprotective potential of silibinin against Helicobacter pylori infection and gastric tumor cells. Life Sci 2020;256:117977. [PMID: 32603822 DOI: 10.1016/j.lfs.2020.117977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
129 Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal 2012;24:2291-6. [PMID: 22820499 DOI: 10.1016/j.cellsig.2012.07.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
130 Kellici TF, Ntountaniotis D, Leonis G, Chatziathanasiadou M, Chatzikonstantinou AV, Becker-baldus J, Glaubitz C, Tzakos AG, Viras K, Chatzigeorgiou P, Tzimas S, Kefala E, Valsami G, Archontaki H, Papadopoulos MG, Mavromoustakos T. Investigation of the Interactions of Silibinin with 2-Hydroxypropyl-β-cyclodextrin through Biophysical Techniques and Computational Methods. Mol Pharmaceutics 2015;12:954-65. [DOI: 10.1021/mp5008053] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
131 Zhang S, Pan H, Peng X, Lu H, Fan H, Zheng X, Xu G, Wang M, Wang J. Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial. J Gastroenterol Hepatol. 2016;31:409-416. [PMID: 26243373 DOI: 10.1111/jgh.13070] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
132 Luangchosiri C, Thakkinstian A, Chitphuk S, Stitchantrakul W, Petraksa S, Sobhonslidsuk A. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complement Altern Med. 2015;15:334. [PMID: 26400476 DOI: 10.1186/s12906-015-0861-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
133 Abdel-Wahhab MA, El-Nekeety AA, Salman AS, Abdel-Aziem SH, Mehaya FM, Hassan NS. Protective capabilities of silymarin and inulin nanoparticles against hepatic oxidative stress, genotoxicity and cytotoxicity of Deoxynivalenol in rats. Toxicon 2018;142:1-13. [PMID: 29248467 DOI: 10.1016/j.toxicon.2017.12.045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
134 Zholobenko A, Mouithys-Mickalad A, Modriansky M, Serteyn D, Franck T. Polyphenols from Silybum marianum inhibit in vitro the oxidant response of equine neutrophils and myeloperoxidase activity. J Vet Pharmacol Ther 2016;39:592-601. [PMID: 27213823 DOI: 10.1111/jvp.12319] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
135 Saito S, Yamamoto Y, Maki T, Hattori Y, Ito H, Mizuno K, Harada-Shiba M, Kalaria RN, Fukushima M, Takahashi R, Ihara M. Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy. Acta Neuropathol Commun 2017;5:26. [PMID: 28376923 DOI: 10.1186/s40478-017-0429-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
136 Martinelli T. Identification of Milk Thistle Shatter‐Resistant Mutant Lines with Altered Lignocellulosic Profile for the Complete Domestication of the Species. Crop Sci 2019;59:2119-27. [DOI: 10.2135/cropsci2019.02.0103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
137 Valentová K, Havlík J, Kosina P, Papoušková B, Jaimes JD, Káňová K, Petrásková L, Ulrichová J, Křen V. Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota. Metabolites 2020;10:E29. [PMID: 31936497 DOI: 10.3390/metabo10010029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
138 Martinelli T, Andrzejewska J, Salis M, Sulas L. Phenological growth stages of Silybum marianum according to the extended BBCH scale: BBCH scale for the growth stages of S. marianum. Ann Appl Biol 2015;166:53-66. [DOI: 10.1111/aab.12163] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 4.1] [Reference Citation Analysis]
139 Lv Y, Xu S, Lyu Y, Zhou S, Du G, Chen J, Zhou J. Engineering enzymatic cascades for the efficient biotransformation of eugenol and taxifolin to silybin and isosilybin. Green Chem 2019;21:1660-7. [DOI: 10.1039/c8gc03728k] [Cited by in Crossref: 14] [Article Influence: 7.0] [Reference Citation Analysis]
140 Malkani N, Naeem A, Ijaz F, Mumtaz S, Ashraf S, Sohail MI. Silybum marianum (milk thistle) improves vancomycin induced nephrotoxicity by downregulating apoptosis. Mol Biol Rep 2020;47:5451-9. [PMID: 32638317 DOI: 10.1007/s11033-020-05635-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
141 Navarro VJ, Belle SH, D'Amato M, Adfhal N, Brunt EM, Fried MW, Reddy KR, Wahed AS, Harrison S; Silymarin in NASH and C Hepatitis (SyNCH) Study Group. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial. PLoS One. 2019;14:e0221683. [PMID: 31536511 DOI: 10.1371/journal.pone.0221683] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
142 Bijak M, Dziedzic A, Synowiec E, Sliwinski T, Saluk-Bijak J. Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes. Nutrients 2017;9:E1022. [PMID: 28914761 DOI: 10.3390/nu9091022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
143 Vilahur G, Casaní L, Peña E, Crespo J, Juan-babot O, Ben-aicha S, Mendieta G, Béjar MT, Borrell M, Badimon L. Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis. International Journal of Cardiology 2018;270:28-35. [DOI: 10.1016/j.ijcard.2018.06.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
144 Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, Luzza F. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. Nutrients 2017;9:E870. [PMID: 28805669 DOI: 10.3390/nu9080870] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
145 Gillessen A, Schmidt HH. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Adv Ther 2020;37:1279-301. [PMID: 32065376 DOI: 10.1007/s12325-020-01251-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 26.0] [Reference Citation Analysis]
146 Ma Q, Wang LH, Jiang JG. Hepatoprotective effect of flavonoids from Cirsium japonicum DC on hepatotoxicity in comparison with silymarin. Food Funct 2016;7:2179-84. [PMID: 27094923 DOI: 10.1039/c6fo00068a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
147 Bijak M, Synowiec E, Sitarek P, Sliwiński T, Saluk-Bijak J. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models. Nutrients 2017;9:E1356. [PMID: 29240674 DOI: 10.3390/nu9121356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
148 Bijak M, Dziedzic A, Saluk-Bijak J. Flavonolignans reduce the response of blood platelet to collagen. Int J Biol Macromol 2018;106:878-84. [PMID: 28842200 DOI: 10.1016/j.ijbiomac.2017.08.091] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
149 Dasgupta A, Klein K. Herbal and Other Dietary Supplements That Are Antioxidants. Antioxidants in Food, Vitamins and Supplements. Elsevier; 2014. pp. 295-315. [DOI: 10.1016/b978-0-12-405872-9.00016-1] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
150 Zhang T, Kawaguchi N, Tsuji K, Hayama E, Furutani Y, Sugiyama H, Nakanishi T. Silibinin Upregulates CXCR4 Expression in Cultured Bone Marrow Cells (BMCs) Especially in Pulmonary Arterial Hypertension Rat Model. Cells 2020;9:E1276. [PMID: 32455728 DOI: 10.3390/cells9051276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
151 Rafizadeh A, Koohi-Dehkordi M, Sorkheh K. Molecular insights of genetic variation in milk thistle (Silybum marianum [L.] Gaertn.) populations collected from southwest Iran. Mol Biol Rep 2018;45:601-9. [PMID: 29882084 DOI: 10.1007/s11033-018-4198-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
152 Valentová K, Purchartová K, Rydlová L, Roubalová L, Biedermann D, Petrásková L, Křenková A, Pelantová H, Holečková-Moravcová V, Tesařová E, Cvačka J, Vrba J, Ulrichová J, Křen V. Sulfated Metabolites of Flavonolignans and 2,3-Dehydroflavonolignans: Preparation and Properties. Int J Mol Sci 2018;19:E2349. [PMID: 30096957 DOI: 10.3390/ijms19082349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
153 Hackett ES, Twedt DC, Gustafson DL. Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease. J Vet Intern Med. 2013;27:10-16. [PMID: 23140176 DOI: 10.1111/jvim.12002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
154 Mohsen AM, Asfour MH, Salama AAA. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes. Drug Development and Industrial Pharmacy 2017;43:2043-54. [DOI: 10.1080/03639045.2017.1361968] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
155 Abenavoli L, Milic N, Rouabhia S, Addolorato G. Pharmacotherapy of acute alcoholic hepatitis in clinical practice. World J Gastroenterol 2014; 20(9): 2159-2167 [PMID: 24605014 DOI: 10.3748/wjg.v20.i9.2159] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
156 Polyak SJ, Oberlies NH, Pécheur EI, Dahari H, Ferenci P, Pawlotsky JM. Silymarin for HCV infection. Antivir Ther 2013;18:141-7. [PMID: 23011959 DOI: 10.3851/IMP2402] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
157 Stoev S, Njobeh P, Zarkov I, Mircheva T, Zapryanova D, Denev S, Dimitrova B. Selected herbal feed additives showing protective effects against ochratoxin A toxicosis in broiler chicks. World Mycotoxin Journal 2019;12:257-68. [DOI: 10.3920/wmj2019.2432] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
158 Sy-Cordero AA, Day CS, Oberlies NH. Absolute configuration of isosilybin A by X-ray crystallography of the heavy atom analogue 7-(4-Bromobenzoyl)isosilybin A. J Nat Prod 2012;75:1879-81. [PMID: 23116206 DOI: 10.1021/np3005369] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
159 Al-sayed E, El-lakkany NM, Seif el-Din SH, Sabra AA, Hammam OA. Hepatoprotective and antioxidant activity of Melaleuca styphelioides on carbon tetrachloride-induced hepatotoxicity in mice. Pharmaceutical Biology 2014;52:1581-90. [DOI: 10.3109/13880209.2014.908398] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
160 Brandon-Warner E, Eheim AL, Foureau DM, Walling TL, Schrum LW, McKillop IH. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Lett 2012;326:88-95. [PMID: 22863537 DOI: 10.1016/j.canlet.2012.07.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
161 Gufford BT, Graf TN, Paguigan ND, Oberlies NH, Paine MF. Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan Glucuronides. Drug Metab Dispos 2015;43:1734-43. [PMID: 26316643 DOI: 10.1124/dmd.115.066076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
162 Cicero AFG, Colletti A, Bellentani S. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence. Nutrients 2018;10:E1153. [PMID: 30142943 DOI: 10.3390/nu10091153] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 16.0] [Reference Citation Analysis]
163 Zhang YM, Xu X, Yu Q, Yu HJ, Liu Y. Drug Displacement Strategy for Treatment of Acute Liver Injury with Cyclodextrin-Liposome Nanoassembly. iScience 2019;15:223-33. [PMID: 31079026 DOI: 10.1016/j.isci.2019.04.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
164 Tao L, Qu X, Zhang Y, Song Y, Zhang SX. Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials. Can J Gastroenterol Hepatol 2019;2019:3192351. [PMID: 30733935 DOI: 10.1155/2019/3192351] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
165 Eo HJ, Park GH, Song HM, Lee JW, Kim MK, Lee MH, Lee JR, Koo JS, Jeong JB. Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. International Immunopharmacology 2015;24:1-6. [DOI: 10.1016/j.intimp.2014.11.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
166 Marzio DLHD, Fenkel JM. Complementary and alternative medications in hepatitis C infection. World J Hepatol 2014; 6(1): 9-16 [PMID: 24653790 DOI: 10.4254/wjh.v6.i1.9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
167 Vostálová J, Tinková E, Biedermann D, Kosina P, Ulrichová J, Rajnochová Svobodová A. Skin Protective Activity of Silymarin and its Flavonolignans. Molecules 2019;24:E1022. [PMID: 30875758 DOI: 10.3390/molecules24061022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
168 Abenavoli L, Izzo AA, Milić N, Cicala C, Santini A, Capasso R. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res 2018;32:2202-13. [PMID: 30080294 DOI: 10.1002/ptr.6171] [Cited by in Crossref: 121] [Cited by in F6Publishing: 97] [Article Influence: 40.3] [Reference Citation Analysis]
169 Antoszczak M, Klejborowska G, Kruszyk M, Maj E, Wietrzyk J, Huczyński A. Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin. Chem Biol Drug Des 2015;86:1378-86. [PMID: 26058448 DOI: 10.1111/cbdd.12602] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
170 Darvishi-khezri H, Salehifar E, Kosaryan M, Karami H, Mahdavi M, Alipour A, Aliasgharian A. Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial. Phytotherapy Research 2018;32:496-503. [DOI: 10.1002/ptr.5995] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
171 Wu C, Liu J, Tang Y, Li Y, Yan Q, Jiang Z. Hepatoprotective Potential of Partially Hydrolyzed Guar Gum against Acute Alcohol-Induced Liver Injury in Vitro and Vivo. Nutrients 2019;11:E963. [PMID: 31035540 DOI: 10.3390/nu11050963] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
172 Martinelli T, Whittaker A, Benedettelli S, Carboni A, Andrzejewska J. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway. Phytochemistry 2017;144:9-18. [PMID: 28863306 DOI: 10.1016/j.phytochem.2017.08.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
173 Cui C, Deng J, Yan L, Liu Y, Fan J, Mu H, Sun H, Wang Y, Han J. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation. Journal of Ethnopharmacology 2017;208:24-35. [DOI: 10.1016/j.jep.2017.06.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
174 Giuliani C, Tani C, Maleci Bini L, Fico G, Colombo R, Martinelli T. Localization of phenolic compounds in the fruits of Silybum marianum characterized by different silymarin chemotype and altered colour. Fitoterapia 2018;130:210-8. [DOI: 10.1016/j.fitote.2018.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
175 Drouet S, Tungmunnithum D, Lainé É, Hano C. Gene Expression Analysis and Metabolite Profiling of Silymarin Biosynthesis during Milk Thistle (Silybum marianum (L.) Gaertn.) Fruit Ripening. Int J Mol Sci 2020;21:E4730. [PMID: 32630801 DOI: 10.3390/ijms21134730] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
176 Fanoudi S, Alavi MS, Karimi G, Hosseinzadeh H. Milk thistle (Silybum Marianum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug Chem Toxicol 2020;43:240-54. [PMID: 30033764 DOI: 10.1080/01480545.2018.1485687] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
177 Milić N, Milošević N, Suvajdžić L, Žarkov M, Abenavoli L. New Therapeutic Potentials of Milk Thistle ( Silybum marianum ). Natural Product Communications 2013;8:1934578X1300801. [DOI: 10.1177/1934578x1300801236] [Cited by in Crossref: 9] [Article Influence: 1.1] [Reference Citation Analysis]
178 Vacek J, Zatloukalová M, Desmier T, Nezhodová V, Hrbáč J, Kubala M, Křen V, Ulrichová J, Trouillas P. Antioxidant, metal-binding and DNA-damaging properties of flavonolignans: a joint experimental and computational highlight based on 7-O-galloylsilybin. Chem Biol Interact 2013;205:173-80. [PMID: 23872255 DOI: 10.1016/j.cbi.2013.07.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
179 Reina M, Martínez A. Is Silybin the Best Free Radical Scavenger Compound in Silymarin? J Phys Chem B 2016;120:4568-78. [PMID: 27149000 DOI: 10.1021/acs.jpcb.6b02807] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
180 Aboelwafa HR, El-Kott AF, Abd-Ella EM, Yousef HN. The Possible Neuroprotective Effect of Silymarin against Aluminum Chloride-Prompted Alzheimer's-Like Disease in Rats. Brain Sci 2020;10:E628. [PMID: 32932753 DOI: 10.3390/brainsci10090628] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
181 Reisinger N, Schaumberger S, Nagl V, Hessenberger S, Schatzmayr G. Milk thistle extract and silymarin inhibit lipopolysaccharide induced lamellar separation of hoof explants in vitro. Toxins (Basel) 2014;6:2962-74. [PMID: 25290524 DOI: 10.3390/toxins6102962] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
182 Soto C, Raya L, Pérez J, González I, Pérez S. Silymarin induces expression of pancreatic Nkx6.1 transcription factor and β-cells neogenesis in a pancreatectomy model. Molecules 2014;19:4654-68. [PMID: 24739928 DOI: 10.3390/molecules19044654] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
183 Mizuno M, Mori K, Tsuchiya K, Takaki T, Misawa T, Demizu Y, Shibanuma M, Fukuhara K. Design, Synthesis, and Biological Activity of Conformationally Restricted Analogues of Silibinin. ACS Omega 2020;5:23164-74. [PMID: 32954167 DOI: 10.1021/acsomega.0c02936] [Reference Citation Analysis]
184 Puschner B, Wegenast C. Mushroom Poisoning Cases in Dogs and Cats: Diagnosis and Treatment of Hepatotoxic, Neurotoxic, Gastroenterotoxic, Nephrotoxic, and Muscarinic Mushrooms. Vet Clin North Am Small Anim Pract 2018;48:1053-67. [PMID: 30077439 DOI: 10.1016/j.cvsm.2018.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
185 Takke A, Shende P. Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation. Nanomedicine: Nanotechnology, Biology and Medicine 2019;21:102057. [DOI: 10.1016/j.nano.2019.102057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
186 Hassan A, Fontana RJ. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019;39:31-41. [PMID: 30003672 DOI: 10.1111/liv.13931] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
187 Soleimani V, Delghandi PS, Moallem SA, Karimi G. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. Phytotherapy Research 2019;33:1627-38. [DOI: 10.1002/ptr.6361] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 21.5] [Reference Citation Analysis]
188 Zhao W, Yang G, Zhong F, Yang N, Zhao X, Qi Y, Fan G. Isolation and purification of diastereoisomeric flavonolignans from silymarin by binary-column recycling preparative high-performance liquid chromatography: Liquid Chromatography. J Sep Science 2014;37:2300-6. [DOI: 10.1002/jssc.201400270] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
189 Ali SO, Darwish HAE, Ismail NAE. Modulatory effects of curcumin, silybin-phytosome and alpha-R-lipoic acid against thioacetamide-induced liver cirrhosis in rats. Chemico-Biological Interactions 2014;216:26-33. [DOI: 10.1016/j.cbi.2014.03.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.9] [Reference Citation Analysis]
190 Kim JY, Kim JY, Jenis J, Li ZP, Ban YJ, Baiseitova A, Park KH. Tyrosinase inhibitory study of flavonolignans from the seeds of Silybum marianum (Milk thistle). Bioorg Med Chem 2019;27:2499-507. [PMID: 30871862 DOI: 10.1016/j.bmc.2019.03.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
191 He M, Xia L, Li J. Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer. Biomolecules 2021;11:1539. [PMID: 34680171 DOI: 10.3390/biom11101539] [Reference Citation Analysis]
192 Verdura S, Cuyàs E, Ruiz-Torres V, Micol V, Joven J, Bosch-Barrera J, Menendez JA. Lung Cancer Management with Silibinin: A Historical and Translational Perspective. Pharmaceuticals (Basel) 2021;14:559. [PMID: 34208282 DOI: 10.3390/ph14060559] [Reference Citation Analysis]
193 Zhu SY, Dong Y, Tu J, Zhou Y, Zhou XH, Xu B. Silybum marianum oil attenuates oxidative stress and ameliorates mitochondrial dysfunction in mice treated with D-galactose. Pharmacogn Mag. 2014;10:S92-S99. [PMID: 24914315 DOI: 10.4103/0973-1296.127353] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
194 Ou Q, Weng Y, Wang S, Zhao Y, Zhang F, Zhou J, Wu X. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.Dig Dis Sci. 2018;63:3398-3408. [PMID: 30191499 DOI: 10.1007/s10620-018-5268-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
195 Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World J Hepatol 2017; 9(10): 491-502 [PMID: 28443154 DOI: 10.4254/wjh.v9.i10.491] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
196 Goupil RC, Davis M, Kaufman A, Roberts D, Mitchell T. Clinical recovery of 5 dogs from amatoxin mushroom poisoning using an adapted Santa Cruz protocol for people. J Vet Emerg Crit Care (San Antonio) 2021;31:414-27. [PMID: 33458945 DOI: 10.1111/vec.13040] [Reference Citation Analysis]
197 Kuo YJ, Chang HP, Chang YJ, Wu HH, Chen CH. Evaluation of nephroprotection of silymarin on contrast-induced nephropathy in liver cirrhosis patients: A population-based cohort study. Medicine (Baltimore) 2018;97:e12243. [PMID: 30212956 DOI: 10.1097/MD.0000000000012243] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
198 Borah A, Paul R, Choudhury S, Choudhury A, Bhuyan B, Das Talukdar A, Dutta Choudhury M, Mohanakumar KP. Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action. CNS Neurosci Ther 2013;19:847-53. [PMID: 24118806 DOI: 10.1111/cns.12175] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
199 Okano JI, Fujise Y, Abe R, Imamoto R, Murawaki Y. Chemoprevention against hepatocellular carcinoma. Clin J Gastroenterol 2011;4:185-97. [PMID: 26189518 DOI: 10.1007/s12328-011-0227-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
200 El-elimat T, Raja HA, Graf TN, Faeth SH, Cech NB, Oberlies NH. Flavonolignans from Aspergillus iizukae , a Fungal Endophyte of Milk Thistle ( Silybum marianum ). J Nat Prod 2014;77:193-9. [DOI: 10.1021/np400955q] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 8.6] [Reference Citation Analysis]
201 Lutsenko SV, Gromovykh TI, Krasnyuk II, Vasilenko IA, Feldman NB. Antihepatotoxic Activity of Liposomal Silibinin. BioNanoSci 2018;8:581-6. [DOI: 10.1007/s12668-018-0512-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
202 Stine JG, Lewis JH. Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol. 2016;10:517-536. [PMID: 26633044 DOI: 10.1586/17474124.2016.1127756] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
203 Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo E, Meyers CM, Reddy KR. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA. 2012;308:274-282. [PMID: 22797645 DOI: 10.1001/jama.2012.8265] [Cited by in Crossref: 99] [Cited by in F6Publishing: 81] [Article Influence: 11.0] [Reference Citation Analysis]
204 Arampatzis DA, Karkanis AC, Tsiropoulos NG. Silymarin content and antioxidant activity of seeds of wild Silybum marianum populations growing in Greece. Ann Appl Biol 2019;174:61-73. [DOI: 10.1111/aab.12470] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
205 Zhu Y, Wang M, Zhang Y, Zeng J, Omari-Siaw E, Yu J, Xu X. In Vitro Release and Bioavailability of Silybin from Micelle-Templated Porous Calcium Phosphate Microparticles. AAPS PharmSciTech 2016;17:1232-9. [PMID: 26669888 DOI: 10.1208/s12249-015-0460-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
206 Gu M, Zhao P, Huang J, Zhao Y, Wang Y, Li Y, Li Y, Fan S, Ma YM, Tong Q, Yang L, Ji G, Huang C. Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor. Front Pharmacol 2016;7:345. [PMID: 27733832 DOI: 10.3389/fphar.2016.00345] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
207 Zakaria S, Hasan RA, Mahmoud MF, El Fayoumi HM, Mahmoud AAA. The concurrent exposure to aluminium and fructose induces liver injury in rats: Protection by monoammonium glycyrrhizinate. Clin Exp Pharmacol Physiol 2020;47:809-20. [PMID: 31944346 DOI: 10.1111/1440-1681.13257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Napolitano JG, Lankin DC, Graf TN, Friesen JB, Chen SN, McAlpine JB, Oberlies NH, Pauli GF. HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin case. J Org Chem 2013;78:2827-39. [PMID: 23461697 DOI: 10.1021/jo302720h] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 9.1] [Reference Citation Analysis]
209 Colturato CP, Constantin RP, Maeda AS, Constantin RP, Yamamoto NS, Bracht A, Ishii-iwamoto EL, Constantin J. Metabolic effects of silibinin in the rat liver. Chemico-Biological Interactions 2012;195:119-32. [DOI: 10.1016/j.cbi.2011.11.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
210 Tvrdý V, Pourová J, Jirkovský E, Křen V, Valentová K, Mladěnka P. Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Med Res Rev 2021;41:2195-246. [PMID: 33587317 DOI: 10.1002/med.21791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
211 Kawaguchi N, Zhang TT, Nakanishi T. Involvement of CXCR4 in Normal and Abnormal Development. Cells 2019;8:E185. [PMID: 30791675 DOI: 10.3390/cells8020185] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
212 Di Costanzo A, Angelico R. Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art. Molecules 2019;24:E2155. [PMID: 31181687 DOI: 10.3390/molecules24112155] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 17.0] [Reference Citation Analysis]
213 Mahi-Birjand M, Yaghoubi S, Abdollahpour-Alitappeh M, Keshtkaran Z, Bagheri N, Pirouzi A, Khatami M, Sineh Sepehr K, Peymani P, Karimzadeh I. Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review. Expert Opin Drug Saf 2020;19:167-86. [PMID: 31914328 DOI: 10.1080/14740338.2020.1712357] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
214 Vue B, Zhang X, Lee T, Nair N, Zhang S, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models. Bioorg Med Chem 2017;25:4845-54. [PMID: 28756013 DOI: 10.1016/j.bmc.2017.07.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
215 Qin N, Hu X, Li S, Wang J, Li Z, Li D, Xu F, Gao M, Hua H. Hypoglycemic effect of silychristin A from Silybum marianum fruit via protecting pancreatic islet β cells from oxidative damage and inhibiting α -glucosidase activity in vitro and in rats with type 1 diabetes. Journal of Functional Foods 2017;38:168-79. [DOI: 10.1016/j.jff.2017.09.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
216 Dajani A, AbuHammour A. Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview. Saudi J Gastroenterol. 2016;22:91-105. [PMID: 26997214 DOI: 10.4103/1319-3767.178527] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
217 Schrieber SJ, Hawke RL, Wen Z, Smith PC, Reddy KR, Wahed AS, Belle SH, Afdhal NH, Navarro VJ, Meyers CM, Doo E, Fried MW. Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. Drug Metab Dispos 2011;39:2182-90. [PMID: 21865319 DOI: 10.1124/dmd.111.040212] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
218 Cho SI, Lee J, Do NY. Protective effect of silymarin against cisplatin-induced ototoxicity. International Journal of Pediatric Otorhinolaryngology 2014;78:474-8. [DOI: 10.1016/j.ijporl.2013.12.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
219 Maldonado-Rojas W, Olivero-Verbel J. Potential interaction of natural dietary bioactive compounds with COX-2. J Mol Graph Model 2011;30:157-66. [PMID: 21803623 DOI: 10.1016/j.jmgm.2011.07.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
220 Zakaria Z, Othman ZA, Nna VU, Mohamed M. The promising roles of medicinal plants and bioactive compounds on hepatic lipid metabolism in the treatment of non-alcoholic fatty liver disease in animal models: molecular targets. Arch Physiol Biochem 2021;:1-17. [PMID: 34153200 DOI: 10.1080/13813455.2021.1939387] [Reference Citation Analysis]
221 Wang L, Huang QH, Li YX, Huang YF, Xie JH, Xu LQ, Dou YX, Su ZR, Zeng HF, Chen JN. Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats. Mol Med Rep. 2018;17:789-800. [PMID: 29115625 DOI: 10.3892/mmr.2017.7958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
222 de Souza Santos V, Peters B, Côco LZ, Alves GM, de Assis ALEM, Nogueira BV, Meyrelles SS, Porto ML, Vasquez EC, Campagnaro BP, Pereira TMC. Silymarin protects against radiocontrast-induced nephropathy in mice. Life Sciences 2019;228:305-15. [DOI: 10.1016/j.lfs.2019.04.061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
223 Zhu SY, Jiang N, Yang J, Tu J, Zhou Y, Xiao X, Dong Y. Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice. Biomed Pharmacother 2018;100:191-7. [PMID: 29428667 DOI: 10.1016/j.biopha.2018.01.144] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
224 Cristofalo R, Bannwart-Castro CF, Magalhães CG, Borges VT, Peraçoli JC, Witkin SS, Peraçoli MT. Silibinin attenuates oxidative metabolism and cytokine production by monocytes from preeclamptic women. Free Radic Res 2013;47:268-75. [PMID: 23316804 DOI: 10.3109/10715762.2013.765951] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
225 Christodoulou E, Kechagia IA, Tzimas S, Balafas E, Kostomitsopoulos N, Archontaki H, Dokoumetzidis A, Valsami G. Serum and tissue pharmacokinetics of silibinin after per os and i.v. administration to mice as a HP-β-CD lyophilized product. Int J Pharm 2015;493:366-73. [PMID: 26222744 DOI: 10.1016/j.ijpharm.2015.07.060] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
226 Gu YY, Huang P, Li Q, Liu YY, Liu G, Wang YH, Yi M, Yan L, Wei XH, Yang L, Hu BH, Zhao XR, Chang X, Sun K, Pan CS, Cui YC, Chen QF, Wang CS, Fan JY, Ma ZZ, Han JY. YangXue QingNao Wan and Silibinin Capsules, the Two Chinese Medicines, Attenuate Cognitive Impairment in Aged LDLR (+/-) Golden Syrian Hamsters Involving Protection of Blood Brain Barrier. Front Physiol 2018;9:658. [PMID: 29910744 DOI: 10.3389/fphys.2018.00658] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
227 Abenavoli L, Bellentani S. Milk thistle to treat non-alcoholic fatty liver disease: dream or reality? Expert Rev Gastroenterol Hepatol. 2013;7:677-679. [PMID: 24134155 DOI: 10.1586/17474124.2013.842893] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
228 Romano B, Pagano E, Montanaro V, Fortunato AL, Milic N, Borrelli F. Novel Insights into the Pharmacology of Flavonoids: PHARMACOLOGY OF FLAVONOIDS. Phytother Res 2013;27:1588-96. [DOI: 10.1002/ptr.5023] [Cited by in Crossref: 151] [Cited by in F6Publishing: 143] [Article Influence: 18.9] [Reference Citation Analysis]
229 Bagherniya M, Nobili V, Blesso CN, Sahebkar A. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. Pharmacol Res 2018;130:213-40. [PMID: 29287685 DOI: 10.1016/j.phrs.2017.12.020] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 18.3] [Reference Citation Analysis]
230 Elbarbary NS, Ismail EAR, Farahat RK, El-hamamsy M. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study. Nutrition 2016;32:41-7. [DOI: 10.1016/j.nut.2015.06.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
231 de Avelar CR, Pereira EM, de Farias Costa PR, de Jesus RP, de Oliveira LPM. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World J Gastroenterol 2017; 23(27): 5004-5017 [PMID: 28785154 DOI: 10.3748/wjg.v23.i27.5004] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
232 Farghali H, Canová NK, Zakhari S. Hepatoprotective properties of extensively studied medicinal plant active constituents: possible common mechanisms. Pharm Biol 2015;53:781-91. [PMID: 25489628 DOI: 10.3109/13880209.2014.950387] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
233 Abenavoli L, Peta V, Milic N. Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series. Annals of Hepatology 2015;14:121-6. [DOI: 10.1016/s1665-2681(19)30809-9] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
234 Kazakova O; Chuiko Institute of Surface Chemistry of National Academy of Sciences of Ukraine. A quantum-chemical study on the antioxidant properties of natural phenolic compounds. Him Fiz Tehnol Poverhni 2016;7:463-7. [DOI: 10.15407/hftp07.04.463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
235 Cui S, Pan XJ, Ge CL, Guo YT, Zhang PF, Yan TT, Zhou JY, He QX, Cheng LH, Wang GJ, Hao HP, Wang H. Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α. Chin J Nat Med 2021;19:401-11. [PMID: 34092291 DOI: 10.1016/S1875-5364(21)60039-0] [Reference Citation Analysis]
236 Kim YC, Na JD, Kwon DY, Park JH. Silymarin prevents acetaminophen-induced hepatotoxicity via up-regulation of the glutathione conjugation capacity in mice. Journal of Functional Foods 2018;49:235-40. [DOI: 10.1016/j.jff.2018.08.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
237 Yang J, Liang J, Shao L, Liu L, Gao K, Zhang JL, Sun Z, Xu W, Lin P, Yu R, Zi J. Green production of silybin and isosilybin by merging metabolic engineering approaches and enzymatic catalysis. Metab Eng 2020;59:44-52. [PMID: 32004707 DOI: 10.1016/j.ymben.2020.01.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
238 Soto C, Raya L, Juárez J, Pérez J, González I. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model. Phytomedicine 2014;21:233-9. [DOI: 10.1016/j.phymed.2013.09.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
239 Lo HY, Li CC, Huang HC, Lin LJ, Hsiang CY, Ho TY. Application of transcriptomics in Chinese herbal medicine studies. J Tradit Complement Med 2012;2:105-14. [PMID: 24716122 DOI: 10.1016/s2225-4110(16)30083-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
240 Li CC, Hsiang CY, Wu SL, Ho TY. Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis. Food Chem Toxicol 2012;50:1568-75. [PMID: 22386810 DOI: 10.1016/j.fct.2012.02.025] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
241 Baghbahadorani FK, Miraj S. The impact of Silymarin on improvement of platelet abnormalities in patients with severe preeclampsia. Electron Physician 2016;8:2436-42. [PMID: 27382456 DOI: 10.19082/2436] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
242 Liu X, Liu W, Wang C, Chen Y, Liu P, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy. Physiol Behav 2021;239:113510. [PMID: 34181930 DOI: 10.1016/j.physbeh.2021.113510] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
243 Alhidary I, Rehman Z, Khan R, Tahir M. Anti-aflatoxin activities of milk thistle ( Silybum marianum ) in broiler. World's Poultry Science Journal 2017;73:559-66. [DOI: 10.1017/s0043933917000514] [Cited by in Crossref: 19] [Article Influence: 9.5] [Reference Citation Analysis]
244 De Marino S, Festa C, Sepe V, Zampella A. Chemistry and Pharmacology of GPBAR1 and FXR Selective Agonists, Dual Agonists, and Antagonists. In: Fiorucci S, Distrutti E, editors. Bile Acids and Their Receptors. Cham: Springer International Publishing; 2019. pp. 137-65. [DOI: 10.1007/164_2019_237] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]